Siemens is reviewing the majority stake in Healthineers, the CFO told Handelsblatt

MUNICH (Reuters) – Siemens AG is reviewing its majority stake in medical technology subsidiary Siemens Healthineers, the German technology group’s chief financial officer Ralf Thomas told the Handelsblatt newspaper.

Synergies with the maker of nuclear magnetic resonance machines and laboratory systems are not big enough to justify a capital commitment of 45 billion euros ($46.91 billion), Thomas told Handelsblatt, referring to how much Siemens’ 75 percent stake is worth.

“We are evaluating the economic opportunities for Siemens AG in the healthcare sector. Next, we’ll take a look at how instrumental Healthineers is as an investment. And then we will draw a conclusion from that,” he said, adding that the results would be presented at the Capital Markets Day in late 2025.

Siemens AG spun off the Erlangen, Germany-based subsidiary in 2018. and floated it on the stock exchange. Until now, Siemens has maintained that it will retain a majority stake in Siemens Healthineers.

However, Thomas recently expressed the prospect of selling about 5% in the foreseeable future to finance the acquisition of US software company Altair.

Thomas said he remains committed to the Mobility train division, which investors have repeatedly called for to be spun off.

“The business is in good hands with us. I see no need to part with him at the moment,” he told Handelsblatt.

($1 = 0.9592 EUR)

(Reporting by Alexander Huebner; Writing by Miranda Murray; Editing by Rod Nickell)